| 000 | 01342 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512014209.0 | ||
| 264 | 0 | _c19890622 | |
| 008 | 198906s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1989.tb05358.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarnett, J A | |
| 245 | 0 | 0 |
_aLack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP). _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cFeb 1989 |
||
| 300 |
_a257-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 |
_aOrosomucoid _xmetabolism |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aQuinidine _xmetabolism |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtherapeutic use |
| 700 | 1 | _aBrenner, D E | |
| 700 | 1 | _aCreaven, P J | |
| 700 | 1 | _aLalka, D | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 27 _gno. 2 _gp. 257-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1989.tb05358.x _zAvailable from publisher's website |
| 999 |
_c2719096 _d2719096 |
||